2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$1.34+$0.01 (+1.14%)
Price as of Jun 03, 2026 7:04 PM EDT- $37.5MMarket Cap
- -82.70%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$1.34+$0.01 (+1.14%)
INMB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.32 | ||
Change | -$0.10 (-7.04%) | ||
Open | $1.42 | ||
High | $1.42 | ||
Low | $1.30 | ||
Previous Close | $1.42 | ||
Volume | 391,894 | ||
30-Day Average Volume | 516,133 | ||
1-Week Change | -5.71% | ||
1-Month Change | -12.58% | ||
1-Year Change | -82.70% | ||
3-Year Change | -83.21% | ||
5-Year Change | -90.13% | ||
Fundamentals | |||
Shares Outstanding | 26.6M | ||
Total Assets | $25.8M | ||
Market Cap | $37.5M | ||
Enterprise Value | $16.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.4M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$5.4M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $17.4M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -7 | ||
PEG | -4 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue